MOLLY STRATTAN: Open Payments
NPI 1104903731 · TIGARD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 36 payments from 15 companies in 2025. Trend: 2023 $1,249 · 2024 $1,116 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $149 |
| Madrigal Pharmaceuticals | 1 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Abbott Laboratories | 3 | $68 |
| Astellas Pharma US Inc | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Exact Sciences Corporation | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
Products named: UBRELVY, REZDIFFRA, ZENPEP, FREESTYLE LIBRE 3, COBENFY, Veozah, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across OR — which companies pay providers there.
